Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials

被引：11
作者：
Chen, Po-Yueh [1 ]
Tsai, Feng-Pai [2 ]
Chen, Mei-Jyh [3 ,4 ]
Yang, Hsin-Yi [5 ]
Wu, Ming-Shiang [3 ,4 ]
Liou, Jyh-Ming [3 ,4 ,6 ]
机构：
[1] Ditmanson Med Fdn Chia Yi Christian Hosp, Internal Med, Chiayi, Taiwan
[2] Natl Taiwan Univ Hosp Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan
[3] Natl Taiwan Univ Hosp, Internal Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 100, Taiwan
[5] Ditmanson Med Fdn Chia Yi Christian Hosp, Clinial Data Ctr, Chiayi, Taiwan
[6] Natl Taiwan Univ, Canc Ctr, Dept Med, Taipei, Taiwan
来源：
GUT | 2023年
关键词：
META-ANALYSIS; HELICOBACTER PYLORI - TREATMENT; TRIPLE THERAPY; 1ST-LINE;
D O I：
10.1136/gutjnl-2023-329826
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 10 条
  • [1] Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication
    Ang, Daphne
    Koo, Seok Hwee
    Chan, Yiong Huak
    Tan, Thean Yen
    Soon, Gaik Hong
    Tan, Chin Kimg
    Lin, Kenneth Weicong
    Krishnasamy-Balasubramanian, Jaydeesh-Khanna
    Wong, Yu Jun
    Kumar, Rahul
    Rajesh, R.
    Tan, Yiyuan
    Ong, Peng-Lan Jeannie
    Tan, Yi-Lyn Jessica
    Li, James Weiquan
    Kwek, Andrew Boon-Eu
    Ang, Tiing Leong
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (03) : 436 - 449
  • [2] Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Chen, Yen-Nien
    Chen, Chieh-Chang
    Fang, Yu-Jen
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Liou, Jyh-Ming
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (10) : 1444 - 1457
  • [3] Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
    Chen, P. -Y.
    Wu, M. -S.
    Chen, C. -Y.
    Bair, M. -J.
    Chou, C. -K.
    Lin, J. -T.
    Liou, J. -M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (05) : 427 - 437
  • [4] Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial
    Chey, William D.
    Megraud, Francis
    Laine, Loren
    Lopez, Luis J.
    Hunt, Barbara J.
    Howden, Colin W.
    [J]. GASTROENTEROLOGY, 2022, 163 (03) : 608 - 619
  • [5] Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication
    Huh, Ki Young
    Chung, Hyewon
    Kim, Yu Kyong
    Lee, SeungHwan
    Bhatia, Siddharth
    Takanami, Yohei
    Nakaya, Ryou
    Yu, Kyung-Sang
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 138 - 144
  • [6] Efficacy and Safety of Vonoprazan-Based versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Clinical Trials
    Lyu, Qiu-Ju
    Pu, Qiang-Hong
    Zhong, Xian-Fei
    Zhang, Jin
    [J]. BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [7] Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
    Malfertheiner, Peter
    Megraud, Francis
    Rokkas, Theodore
    Gisbert, Javier P.
    Liou, Jyh-Ming
    Schulz, Christian
    Gasbarrini, Antonio
    Hunt, Richard H.
    Leja, Marcis
    O'Morain, Colm
    Rugge, Massimo
    Suerbaum, Sebastian
    Tilg, Herbert
    Sugano, Kentaro
    El-Omar, Emad M.
    [J]. GUT, 2022, 71 (09) : 1724 - 1762
  • [8] Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
    Murakami, Kazunari
    Sakurai, Yuuichi
    Shiino, Madoka
    Funao, Nobuo
    Nishimura, Akira
    Asaka, Masahiro
    [J]. GUT, 2016, 65 (09) : 1439 - 1446
  • [9] Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis
    Rokkas, Theodore
    Gisbert, Javier P.
    Malfertheiner, Peter
    Niv, Yaron
    Gasbarrini, Antonio
    Leja, Marcis
    Megraud, Francis
    O'Morain, Colm
    Graham, David Y.
    [J]. GASTROENTEROLOGY, 2021, 161 (02) : 495 - +
  • [10] Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
    Suzuki, Sho
    Gotoda, Takuji
    Kusano, Chika
    Ikehara, Hisatomo
    Ichijima, Ryoji
    Ohyauchi, Motoki
    Ito, Hirotaka
    Kawamura, Masashi
    Ogata, Yohei
    Ohtaka, Masahiko
    Nakahara, Moriyasu
    Kawabe, Koichi
    [J]. GUT, 2020, 69 (06) : 1019 - +
1